Abiopharma

Epsium Enterprise Limited Launches New Investor Relations Website

Diana Shipping Inc. Reaffirms Offer to Acquire Genco Shipping & Trading

Churchill Downs Incorporated Announces State of Maryland’s Decision to Acquire the Preakness IP Rights

Teva Pharmaceutical Industries Ltd. - Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome

Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome

Other Report or Announcement

Comstock Appoints former Blackstone and Citigroup Leader David Hirsh to Board of Directors

Scage Future Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Contango Announces Results of the 2026 Virtual Annual Meeting of Stockholders

BTQ TECHNOLOGIES ANNOUNCES AT-THE-MARKET EQUITY PROGRAM